APOE expression and secretion are modulated by mitochondrial dysfunction
- Emory University, United States
- Middlebury College, United States
- University of Missouri, United States
- Johns Hopkins University, United States
- University of Miami, United States
Abstract
Mitochondria influence cellular function through both cell-autonomous and non-cell autonomous mechanisms, such as production of paracrine and endocrine factors. Here, we demonstrate that mitochondrial regulation of the secretome is more extensive than previously appreciated, as both genetic and pharmacological disruption of the electron transport chain caused upregulation of the Alzheimer's disease risk factor apolipoprotein E (APOE) and other secretome components. Indirect disruption of the electron transport chain by gene editing of SLC25A mitochondrial membrane transporters as well as direct genetic and pharmacological disruption of either complexes I, III, or the copper-containing complex IV of the electron transport chain, elicited upregulation of APOE transcript, protein, and secretion, up to 49-fold. These APOE phenotypes were robustly expressed in diverse cell types and iPSC-derived human astrocytes as part of an inflammatory gene expression program. Moreover, age- and genotype-dependent decline in brain levels of respiratory complex I preceded an increase in APOE in the 5xFAD mouse model. We propose that mitochondria act as novel upstream regulators of APOE-dependent cellular processes in health and disease.
Data availability
The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium via the PRIDE (Deutsch et al., 2020) partner repository with dataset identifiers: PXD038974 and PXD017501.RNAseq data were deposited in GEO with accession GSE201889
-
APOE Expression and Secretion are Modulated by Copper-Dependent and -Independent Mitochondrial DysfunctionNCBI Gene Expression Omnibus, GSE201889.
Article and author information
Author details
Steven Michael Claypool
Funding
National Institute on Aging (1RF1AG060285)
- Victor Faundez
ARCS Foundation Award
- Alicia R Lane
Alzheimer's Disease Research Center, Emory University (P30AG066511)
- Victor Faundez
National Institute on Aging (U01AG061357)
- Nicholas T Seyfried
National Institute of Neurological Disorders and Stroke (F31AG067623)
- Meghan E Wynne
National Institute of Neurological Disorders and Stroke (5T32NS007480)
- Meghan E Wynne
National Institute of Neurological Disorders and Stroke (R01NS11430)
- Srikant Rangaraju
National Institute on Aging (RF1AG071587)
- Srikant Rangaraju
National Institute on Aging (F32AG064862)
- Sruti Rayaprolu
National Institute of Neurological Disorders and Stroke (1F31NS127419)
- Alicia R Lane
The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
Reviewing Editor
- Agnieszka Chacinska, IMol Polish Academy of Sciences, Poland
Version history
- Preprint posted: May 11, 2022 (view preprint)
- Received: December 23, 2022
- Accepted: May 11, 2023
- Accepted Manuscript published: May 12, 2023 (version 1)
- Version of Record published: May 31, 2023 (version 2)
Copyright
© 2023, Wynne et al.
This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 3,779
- Page views
-
- 478
- Downloads
-
- 7
- Citations
Article citation count generated by polling the highest count across the following sources: Crossref, PubMed Central, Scopus.
Download links
A two-part list of links to download the article, or parts of the article, in various formats.
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
APOE expression and secretion are modulated by mitochondrial dysfunction
eLife 12:e85779.
https://doi.org/10.7554/eLife.85779
Further reading
-
- Cell Biology
High-altitude polycythemia (HAPC) affects individuals living at high altitudes, characterized by increased red blood cells (RBCs) production in response to hypoxic conditions. The exact mechanisms behind HAPC are not fully understood. We utilized a mouse model exposed to hypobaric hypoxia (HH), replicating the environmental conditions experienced at 6000 m above sea level, coupled with in vitro analysis of primary splenic macrophages under 1% O2 to investigate these mechanisms. Our findings indicate that HH significantly boosts erythropoiesis, leading to erythrocytosis and splenic changes, including initial contraction to splenomegaly over 14 days. A notable decrease in red pulp macrophages (RPMs) in the spleen, essential for RBCs processing, was observed, correlating with increased iron release and signs of ferroptosis. Prolonged exposure to hypoxia further exacerbated these effects, mirrored in human peripheral blood mononuclear cells. Single-cell sequencing showed a marked reduction in macrophage populations, affecting the spleen’s ability to clear RBCs and contributing to splenomegaly. Our findings suggest splenic ferroptosis contributes to decreased RPMs, affecting erythrophagocytosis and potentially fostering continuous RBCs production in HAPC. These insights could guide the development of targeted therapies for HAPC, emphasizing the importance of splenic macrophages in disease pathology.
-
- Cell Biology
Mapping proteins in and associated with the Golgi apparatus reveals how this cellular compartment emerges in budding yeast and progresses over time.
